{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T08:40:07Z","timestamp":1793176807093,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005247","name":"University of British Columbia","doi-asserted-by":"publisher","award":["H20-02726"],"award-info":[{"award-number":["H20-02726"]}],"id":[{"id":"10.13039\/501100005247","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004888","name":"Centre Hospitalier Universitaire de Qu\u00e9bec","doi-asserted-by":"publisher","award":["2018-3745"],"award-info":[{"award-number":["2018-3745"]}],"id":[{"id":"10.13039\/501100004888","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","award":["32774 PT"],"award-info":[{"award-number":["32774 PT"]}],"id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.clgc.2023.12.004","type":"journal-article","created":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T21:18:36Z","timestamp":1702588716000},"page":"354-359.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Circulating Basophils as a Prognostic Marker for Response to Bacillus Calmette-Gu\u00e9rin"],"prefix":"10.1016","volume":"22","author":[{"given":"Genevi\u00e8ve","family":"Tr\u00e9panier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Nykopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rapha\u00eblla","family":"Rosebush-Mercier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Typhaine","family":"Gris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2949-3289","authenticated-orcid":false,"given":"Jonathan","family":"Fadel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2919-7068","authenticated-orcid":false,"given":"Peter C.","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5762-5787","authenticated-orcid":false,"given":"Paul","family":"Toren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.clgc.2023.12.004_bib0001","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1001\/jama.2020.17598","article-title":"Bladder cancer: a review","volume":"324","author":"Lenis","year":"2020","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.clgc.2023.12.004_bib0002","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3390\/diagnostics10010039","article-title":"Biomarkers for bladder cancer diagnosis and surveillance: a comprehensive review","volume":"10","author":"Batista","year":"2020","journal-title":"Diagnostics (Basel)"},{"issue":"2","key":"10.1016\/j.clgc.2023.12.004_bib0003","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/jso.24132","article-title":"Predictors of costs associated with radical cystectomy for bladder cancer: a population-based retrospective cohort study in the province of Quebec, Canada","volume":"113","author":"Santos","year":"2016","journal-title":"J Surg Oncol"},{"issue":"3","key":"10.1016\/j.clgc.2023.12.004_bib0004","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.clgc.2023.12.004_bib0005","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.eururo.2003.10.006","article-title":"Prognosis of muscle-invasive bladder cancer: difference between primary and progressive tumours and implications for therapy","volume":"45","author":"BPh","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2023.12.004_bib0006","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.3389\/fgene.2019.01237","article-title":"Validation of a novel, sensitive, and specific urine-based test for recurrence surveillance of patients with non-muscle-invasive bladder cancer in a comprehensive multicenter study","volume":"10","author":"Batista","year":"2019","journal-title":"Front Genet"},{"issue":"35","key":"10.1016\/j.clgc.2023.12.004_bib0007","doi-asserted-by":"crossref","first-page":"59527","DOI":"10.18632\/oncotarget.18521","article-title":"The prognostic and diagnostic value of circulating tumor cells in bladder cancer and upper tract urothelial carcinoma: a meta-analysis of 30 published studies","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.clgc.2023.12.004_bib0008","doi-asserted-by":"crossref","first-page":"137","DOI":"10.5152\/tud.2013.029","article-title":"The value of the NMP22 test for superficial bladder cancer diagnosis and follow-up","volume":"39","author":"Do\u011fan","year":"2013","journal-title":"Turk J Urol"},{"key":"10.1016\/j.clgc.2023.12.004_bib0009","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.12688\/f1000research.11697.1","article-title":"Recent advances in understanding basophil functions in vivo","volume":"6","author":"Voehringer","year":"2017","journal-title":"F1000Res"},{"key":"10.1016\/j.clgc.2023.12.004_bib0010","series-title":"Tumor Microenvironment: Hematopoietic Cells \u2013 Part A. Advances in Experimental Medicine and Biology","first-page":"21","article-title":"Basophils in tumor microenvironment and surroundings","author":"Marone","year":"2020"},{"key":"10.1016\/j.clgc.2023.12.004_bib0011","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.3389\/fimmu.2020.02103","article-title":"Is there a role for basophils in cancer?","volume":"11","author":"Marone","year":"2020","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.clgc.2023.12.004_bib0012","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00345-019-02754-2","article-title":"Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Gu\u00e9rin after transurethral resection of the bladder tumor","volume":"38","author":"Ferro","year":"2020","journal-title":"World J Urol"},{"issue":"19","key":"10.1016\/j.clgc.2023.12.004_bib0013","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1002\/sim.3623","article-title":"The estimation of average hazard ratios by weighted Cox regression","volume":"28","author":"Schemper","year":"2009","journal-title":"Stat Med"},{"issue":"1","key":"10.1016\/j.clgc.2023.12.004_bib0014","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.eururo.2011.09.026","article-title":"Markers predicting response to bacillus calmette-gu\u00e9rin immunotherapy in high-risk bladder cancer patients: a systematic review","volume":"61","author":"Zuiverloon","year":"2012","journal-title":"Eur Urol"},{"issue":"12","key":"10.1016\/j.clgc.2023.12.004_bib0015","doi-asserted-by":"crossref","first-page":"539.e1","DOI":"10.1016\/j.urolonc.2022.09.024","article-title":"Analysis of sex-based differences to Bacillus Calmette-Gu\u00e9rin for non-muscle invasive bladder cancer","volume":"40","author":"Fadel","year":"2022","journal-title":"Urol Oncol"},{"issue":"6","key":"10.1016\/j.clgc.2023.12.004_bib0016","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.clgc.2018.07.003","article-title":"Validation of neutrophil-to-lymphocyte ratio in a multi-institutional cohort of patients with t1g3 non\u2013muscle-invasive bladder cancer","volume":"16","author":"Vartolomei","year":"2018","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.clgc.2023.12.004_bib0017","doi-asserted-by":"crossref","unstructured":"Ferro M, Bab\u0103 DF, de Cobelli O, et al. Neutrophil percentage-to-albumin ratio predicts mortality in bladder cancer patients treated with neoadjuvant chemotherapy followed by radical cystectomy. Future Sci OA. 7(7):FSO709. doi:10.2144\/fsoa-2021-0008.","DOI":"10.2144\/fsoa-2021-0008"},{"issue":"9","key":"10.1016\/j.clgc.2023.12.004_bib0018","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.urolonc.2018.05.014","article-title":"Prognostic role of pretreatment neutrophil-to-lymphocyte ratio (NLR) in patients with non-muscle-invasive bladder cancer (NMIBC): A systematic review and meta-analysis","volume":"36","author":"Vartolomei","year":"2018","journal-title":"Urol Oncol"},{"issue":"2","key":"10.1016\/j.clgc.2023.12.004_bib0019","first-page":"180","article-title":"Accuracy of the European Association of Urology (EAU) NMIBC 2021 scoring model in predicting progression in a large cohort of HG T1 NMIBC patients treated with BCG","volume":"75","year":"2023","journal-title":"Minerva Urol Nephrol"},{"issue":"3","key":"10.1016\/j.clgc.2023.12.004_bib0020","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3390\/diagnostics12030586","article-title":"Modified Glasgow prognostic score as a predictor of recurrence in patients with high grade non-muscle invasive bladder cancer undergoing intravesical bacillus Calmette\u2013Guerin immunotherapy","volume":"12","author":"Ferro","year":"2022","journal-title":"Diagnostics (Basel)"},{"issue":"5","key":"10.1016\/j.clgc.2023.12.004_bib0021","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.euo.2018.06.006","article-title":"Systemic inflammatory markers and oncologic outcomes in patients with high-risk non\u2013muscle-invasive urothelial bladder cancer","volume":"1","author":"Cantiello","year":"2018","journal-title":"Eur Urol Oncol"},{"issue":"2","key":"10.1016\/j.clgc.2023.12.004_bib0022","doi-asserted-by":"crossref","first-page":"626","DOI":"10.21037\/tau-20-1272","article-title":"Systemic combining inflammatory score (SCIS): a new score for prediction of oncologic outcomes in patients with high-risk non-muscle-invasive urothelial bladder cancer","volume":"10","author":"Ferro","year":"2021","journal-title":"Transl Androl Urol"},{"issue":"1","key":"10.1016\/j.clgc.2023.12.004_bib0023","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.atherosclerosis.2007.12.058","article-title":"Relation of smoking status to a panel of inflammatory markers: the Framingham offspring","volume":"201","author":"Levitzky","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clgc.2023.12.004_bib0024","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/ni.1674","article-title":"The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells","volume":"10","author":"Yu","year":"2023","journal-title":"Nat Immunol"},{"issue":"7","key":"10.1016\/j.clgc.2023.12.004_bib0025","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1158\/0008-5472.CAN-15-1801-T","article-title":"Basophil recruitment into tumor-draining lymph nodes correlates with Th2 inflammation and reduced survival in pancreatic cancer patients","volume":"76","author":"De Monte","year":"2016","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.clgc.2023.12.004_bib0026","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.immuni.2012.11.014","article-title":"Inflammatory monocytes recruited to allergic skin acquire an anti-inflammatory M2 phenotype via basophil-derived interleukin-4","volume":"38","author":"Egawa","year":"2013","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.clgc.2023.12.004_bib0027","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/cam4.1356","article-title":"Peripheral blood clinical laboratory variables associated with outcomes following combination nivolumab and ipilimumab immunotherapy in melanoma","volume":"7","author":"Rosner","year":"2018","journal-title":"Cancer Med"},{"key":"10.1016\/j.clgc.2023.12.004_bib0028","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fphys.2018.00167","article-title":"Antineoplastic drug-induced cardiotoxicity: a redox perspective","volume":"9","author":"Varricchi","year":"2018","journal-title":"Front Physiol"},{"issue":"1","key":"10.1016\/j.clgc.2023.12.004_bib0029","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1470-2045(20)30540-4","article-title":"Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial","volume":"22","author":"Boorjian","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clgc.2023.12.004_bib0030","doi-asserted-by":"crossref","first-page":"1035276","DOI":"10.3389\/fimmu.2022.1035276","article-title":"Current landscape and future directions of bispecific antibodies in cancer immunotherapy","volume":"13","author":"Wei","year":"2022","journal-title":"Front Immunol"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767323002719?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767323002719?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T08:28:45Z","timestamp":1793176125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767323002719"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S1558767323002719"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2023.12.004","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating Basophils as a Prognostic Marker for Response to Bacillus Calmette-Gu\u00e9rin","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2023.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}